A song worth more than a listen

Korn releases exclusive download to benefit T1D research What can one voice raised against type 1 diabetes (T1D) do? If you’re Jonathan Davis, lead singer of acclaimed rock band Korn, one voice can reach millions to help people living with T1D. Jonathan’s young son, Zeppelin, was diagnosed with T1D just over a year ago, and […]

Arizona Cyclist Rides 104 Miles for JDRF

Arizona Cyclist Rides 104 Miles for JDRF

By Alyssa Hillman JDRF’s cyclists came together for the Ride to Cure Diabetes at the 32nd El Tour de Tucson at the end of National Diabetes Awareness Month. El Tour de Tucson is one of the largest bicycling events in America, and the JDRF Ride to Cure Diabetes program has raised $20 million for type […]

License To Cure Raises Over $700,000

License To Cure Raises Over $700,000

By Alyssa Hillman ONE NIGHT – License To Cure was an unforgettable and rewarding evening at Omni Scottsdale Resort & Spa at Montelucia and more than $700,000 was raised for type 1 diabetes research. On Saturday, November 8, 2014, JDRF’s 450 guests filed in to the James Bond themed event and were welcomed by a […]

Christina's Original Work

Christina’s Champions For a Cure Successful with Tucson Walk

By Alyssa Hillman On October 25th, the Southern Arizona Branch kicked off National Diabetes Awareness Month early with their annual Walk to Cure Diabetes Celebrating Ron Santo for JDRF. Over 2,000 walkers and more than 20 vendors and sponsors gathered in Tucson at Rillito Park that Saturday morning, ready for a great time while supporting […]

Halloween with T1D

Halloween with T1D

By Alyssa Hillman Eating too much candy is a common problem kids experience around Halloween, but how do parents handle this treat-filled holiday with a T1D child? The Rose family, from Peoria, celebrates just like most households. They dress up, eat dinner together, and then visit their neighbors hoping to get some treats tossed into […]

Making the T1D Vaccine a Reality

Nanoparticle-based vaccine is designed to re-educate the immune system and halt the attack on the pancreas Over the last three years, Selecta Bioscience, a clinical stage biotechnology company, has been developing nanoparticles called Synthetic Vaccine Particle (SVP) as an immunotherapy for Type 1 diabetes (T1D) with support from JDRF and it was announced this week […]

Paul Laiklind, President & CEO, ViaCyte

JDRF Funded Research Receives FDA Approval

New Trial Tests Potential Diabetes Cure By Alyssa Hillman (PHOENIX)—ViaCyte, a leader in the innovative medical world, announced that the FDA approved their encapsulation device for human clinical trials. More than 100 JDRF supporters attended Desert Southwest Chapter’s Research Update, at the home of Bo and Lani Calbert of Paradise Valley on October 2nd, where […]

JDRF-Funded Research Leads to Beta Cell Replacement Breakthrough

A new method for converting stem cells to beta cells could speed encapsulated cell replacement product development and research to cure type 1 diabetes Insulin therapy has long been the only method of treating type 1 diabetes (T1D), but a major breakthrough in producing replacement beta cells is bringing new hope that more effective, alternative […]

CGM-Medicare Bill Introduced in House

JDRF Commends U.S. Representatives Reed, DeGette and Whitfield for Introducing Continuous Glucose Monitor (CGM) Coverage Legislation JDRF commends U.S. Representatives Tom Reed (R-NY), Diana DeGette (D-CO) and Ed Whitfield (R-KY) for introducing legislation, H.R. 5644, the ‘Medicare CGM Access Act of 2014,’ calling for continuous glucose monitor (CGM) coverage by Medicare. This legislation (which now […]

Unlocking Type 1 Diabetes Data

JDRF partners with Tidepool on data integration software for better type 1 diabetes management JDRF is partnering with the non-profit organization Tidepool to develop a new data integration tool for people with type 1 diabetes (T1D) who use insulin pumps, continuous glucose monitors, or blood glucose meters. The new tool at the center of the […]